Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This study aims to compare the novel single-port robotic partial prostatectomy to High-intensity focused ultrasound (HIFU) in patients with low to intermediate risk localized prostate cancer. These interventions have become acceptable focal therapies prevalent with beneficial oncologic outcomes and therefore need to be examined further.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzony biopsją rak prostaty na wczesnym etapie (T1a, T2a, T2b lub T2c)
- •Wynik MRI prostaty wykazujący zmianę o charakterze podejrzanym (PIRADs 3 lub wyżej)
- •Poziom PSA we krwi nie wyższy niż 10 ng/ml
- •Rak prostaty o niskiej złośliwości (wynik Gleasona 3+4 lub mniej)
- •Przeprowadzone badanie MRI prostaty wg standardowych wymogów
- •Oczekiwana długość życia ponad 10 lat
- •Wiek powyżej 18 lat
- •Zdolność do zrozumienia i podpisania świadomej zgody
Simplified criteria — AI translation
Trial details
- Minimum age
- 19 Years
- Last updated (source)
- August 6, 2026
- Sex
- Male only
Therapies / drugs in trial
Locations (1)
Glickman Urological & Kidney Institute, Cleveland Clinic Foundation, Case Comprehensive Cancer Center
Cleveland, United States
Trial contact
Jihad Kaouk, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/7/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.